Piero Musiani

发表

This information is current as Host T Cell Antitumor Response Requires CD40-Apc Signaling to Boost the Vaccine Synergizes with GM-CSF and OX40 Ligand-Transduced Tumor Cell

Mario P. Colombo, Giorgia Gri, Elena M. Gallo, 2013 .

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2001, The Journal of experimental medicine.

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.

Piero Musiani, Guido Forni, Pier-Luigi Lollini, 2003, The Journal of clinical investigation.

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.

Piero Musiani, Remo Sanges, Federica Cavallo, 2004, The Journal of clinical investigation.

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2005, The American journal of pathology.

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Ilaria Rossi, 1998, The Journal of experimental medicine.

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2005, Cancer Immunology, Immunotherapy.

Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2004, Cancer Research.

Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells

Flavia Frabetti, Filippo Belardelli, Piero Musiani, 1998, Clinical & Experimental Metastasis.

Immunobiology of her-2/neu transgenic mice.

Piero Musiani, Guido Forni, P. Musiani, 2004, Breast disease.

Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity

Piero Musiani, Federica Cavallo, Manuela Iezzi, 2005, Clinical Cancer Research.

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

Piero Musiani, Federica Cavallo, Manuela Iezzi, 2004, Cancer research.

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2

Piero Musiani, Patrizia Nanni, Guido Forni, 2000, The Journal of Immunology.